| Advantages | Derived from normal human intestinal stem cells, these organoids demonstrate robust self-organization, long-term growth, and renewal capacity, containing multiple mature intestinal epithelial cell types. |
| Species | Human |
| Product Type | Tissue-derived Organoid |
| Growth Properties | Embedded 3D Culture |
| Growth Conditions | Cultured at 37°C under 95% air and 5% CO2. |
| Quality Control | Negative for mycoplasma, bacteria, yeast, and fungi. |
| Tissue | Intestine |
| Disease | Normal |
| Format | Frozen |
| Organoid Characterization | They exhibit polarity and recapitulate, to a significant extent, the structure and function of native intestinal tissue. Under light microscopy, they typically appear as cystic or budding structures with a central lumen surrounded by tightly arranged columnar epithelial cells. The lumen boundary is well-defined, and cells appear bright and transparent with characteristic morphology. |
| Applications | Tissue-derived organoids are broadly utilized in drug screening, disease modeling, mechanistic research, personalized medicine, and regenerative medicine. Through accurate modeling of disease states, they provide a robust platform for assessing patient-specific drug responses and informing individualized treatment design. In addition, these organoids enable the development of novel therapeutic approaches, especially in cancer research and organ regeneration, delivering precise experimental systems that significantly advance precision medicine. |
| Storage | Liquid Nitrogen |
| Shipping Information | Dry Ice |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.